Progyny (PGNY) Liabilities and Shareholders Equity (2018 - 2026)

Progyny (PGNY) has 9 years of Liabilities and Shareholders Equity data on file, last reported at $698.3 million in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 4.37% year-over-year to $698.3 million in Q1 2026; TTM through Mar 2026 was $3.0 billion, a 11.16% increase from a year earlier, with the FY2025 full-year figure at $742.4 million, up 22.29% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $698.3 million, down from $742.4 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for PGNY reached as high as $795.2 million in Q3 2025 and fell as low as $415.5 million in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $649.8 million across 5 years, with a median of $681.5 million in 2023.
• Across the five-year window, Liabilities and Shareholders Equity surged 56.36% in 2023 and declined 19.76% in 2024, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $543.0 million in 2022, then surged by 39.34% to $756.6 million in 2023, then retreated by 19.76% to $607.1 million in 2024, then grew by 22.29% to $742.4 million in 2025, then retreated by 5.94% to $698.3 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $698.3 million in Q1 2026, $742.4 million in Q4 2025, and $795.2 million in Q3 2025.